PI Post Acute Access Act

This bill would allow Medicare to provide separate payments to skilled nursing facilities for the items and services required to administer intravenous immune globin (IVIG). These payments would specifically apply to the treatment of patients with primary immune deficiency diseases, which are rare genetic disorders that weaken the immune system.

This bill affects Medicare patients with primary immune deficiency diseases, which are rare genetic disorders that impair the immune system. It also impacts skilled nursing facilities by allowing them to receive separate Medicare payments for the items and services required to administer intravenous immune globin (IVIG) to these patients.

• Medicare payment for intravenous immune globin (IVIG) administration. The bill authorizes separate Medicare payments to skilled nursing facilities for the items and services required to administer IVIG to patients.
• Targeted coverage for primary immune deficiency diseases. The payment provisions apply specifically to treatments for patients with rare genetic disorders that impair the immune system and increase infection vulnerability.

This bill modifies Medicare payment rules to allow for separate reimbursement to skilled nursing facilities for the administration of intravenous immune globin (IVIG) to patients with primary immune deficiency diseases.

The bill aims to facilitate access to intravenous immune globin (IVIG) for Medicare beneficiaries in skilled nursing facilities by authorizing separate payments for the items and services required to treat primary immune deficiency diseases.